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LETTER TO THE EDITOR 
Sir, 
Immunoh is tochemica l  identif ication of  
chodrocalc in in synovial  chondromatos is  
We previously reported a patient with synovial 
chondromatosis of the knee joint, in which 
elevated levels of chondrocalcin (carboxy-terminal 
type II procollagen peptide) in the synovial fluid 
was observed [1]. Because the articular surface was 
macroscopically normal, we assumed that excess 
chondrocalcin would have been due to increased 
production by metaplastic synovial cartilage and 
discussed the role of this excess for diagnosis of the 
disease. 
In response to our letter, Dr Shinmei kindly 
advised us to confirm the existence of chondrocal- 
cin in the pathological synovium by immunohisto- 
chemical techniques. We, therefore, performed 
immunostaining of chondrocalcin using anti-chon- 
drocalcin polyclonal antibody, kindly provided by 
Dr Ito of Teijin Research Center (Iwakuni, 
Yamaguchi, Japan). The specificity of the anti- 
serum was tested using an established enzyme 
immunoassay [2], confirming specific reaction 
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with human and bovine carboxy-terminal type 
II procollagen peptide and no cross-reactivity 
with type I and H collagen, hyaluronan, 
and osteocalcin. The results are shown in Fig. 1 
and 2. Most of the metaplastic hondrocytes in 
the synovium of our previously reported case 
showed strongly positive staining by anti-chondro- 
calcin (Fig. 1). Some chondrocytes in free bodies 
also showed positive staining (Fig. 2). Because 
chondrocytes in normal articular carti lage are 
known to show negative staining by the same 
method [3], we believe that the major source of 
chondrocalcin was the metaplastic cartilage. No 
diagnostic laboratory findings have been so far 
indicative of synovial chondromatosis, but the 
disease should be recognized as one of the 
arthropathies in which excess chondrocalcin can 
be observed. 
Milgram suggested that cartilage metaplasia 
indicates active intrasynovial disease, which is 
self-limiting and becomes quiescent in a later 
period [4]. On this basis, he recommended 
synovectomy with removal of loose bodies when 
active intrasynovial disease is present, but 
removal of loose bodies alone in the late phase. 
As production of chondrocalcin is l inked to pro- 
duction of type II procollagen, levels of chondro- 
calcin may represent the degree of ongoing 
FIG. 1. Immunolocalization f chondrocalcin i  the synovial cartilage (×40). 
287 
288 Let ter  to  the  ed i to r  
FIG. 2. Immunolocalization f chondrocalcin the free body (x40). 
carti lage formation, and hence present disease 
status, active or quiescent. We consider that the 
validity of evaluation of chondrocalcin i  assess- 
ing the disease activity in synovial chondromatosis 
should be examined by further study. 
Lastly, we would like to express our respect to 
Dr Shinmei, who died of cancer on June 1, 
1995. 
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